Zurich Insurance Group LTD Neurocrine Biosciences Inc Transaction History
Zurich Insurance Group LTD
- $12.4 Billion
- Q2 2025
A detailed history of Zurich Insurance Group LTD transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Zurich Insurance Group LTD holds 211,911 shares of NBIX stock, worth $29.2 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
211,911Holding current value
$29.2 Million% of portfolio
0.21%Shares
1 transactions
Others Institutions Holding NBIX
# of Institutions
658Shares Held
102MCall Options Held
290KPut Options Held
214K-
Black Rock Inc. New York, NY14.2MShares$1.95 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.81MShares$1.35 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.57MShares$767 Million0.42% of portfolio
-
State Street Corp Boston, MA4.47MShares$615 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.09MShares$425 Million0.04% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13.2B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...